Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$12.39 USD
-0.05 (-0.40%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $12.40 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Arcus Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RCUS 12.39 -0.05(-0.40%)
Will RCUS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RCUS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RCUS
Arcus Biosciences, Inc. (RCUS) Reports Break-Even Earnings for Q2
Pacira (PCRX) Tops Q2 Earnings Estimates
RCUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates
Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates
Moderna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar?
Other News for RCUS
RCUS's price falls by 0.4% on September 20, though its technical setup remains stable.
RCUS forms Stochastic Reached Overbought on September 19
Technical picture remains unchanged for RCUS after it rises 2.38% on September 18
The technical outlook for RCUS is unchanged after it rises 1.47% on September 16
RCUS's price rises by 0.52% on September 15, though its technical setup remains stable.